[1]Patent:WO2008/148867,2008,A2.Locationinpatent:Page/Pagecolumn139-140
[1]Patent:WO2008/148867,2008,A2.Locationinpatent:Page/Pagecolumn135-136
[1]Patent:WO2008/148867,2008,A2.Locationinpatent:Page/Pagecolumn140-141
[1]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.2609-2613
Title: Baffert F, et al. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. Mol Cancer Ther. 2010 Jul;9(7):1945-55.
Title: Cheon JH, et al. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochem Biophys Res Commun. 2017 Sep 2;490(4):1176-1182.